Faculty Opinions recommendation of Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.

2015 ◽  
Author(s):  
Philip Rosenthal
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Retrospective Analysis ◽  
Hepatitis C Virus Infection ◽  
Phase 3 ◽  
Safety And Efficacy ◽  
Black Patients

scholarly journals Safety and efficacy of ledipasvir‐sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data

Hepatology ◽  
2015 ◽  
Vol 63 (2) ◽  
pp. 437-444 ◽  
Author(s):  
Julius M. Wilder ◽  
Lennox J. Jeffers ◽  
Natarajan Ravendhran ◽  
Mitchell L. Shiffman ◽  
John Poulos ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Retrospective Analysis ◽  
Hepatitis C Virus Infection ◽  
Phase 3 ◽  
Safety And Efficacy ◽  
Black Patients

scholarly journals Generic Ledipasvir-Sofosbuvir Treatment for Adolescents With Chronic Hepatitis C Virus Infection

2019 ◽  
Vol 9 (3) ◽  
pp. 386-389 ◽  
Author(s):  
Hanan M Fouad ◽  
Magda A Sabry ◽  
Amal Ahmed ◽  
Mohamed Hassany ◽  
Mohamed F Al Soda ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Liver Function ◽  
Response Rate ◽  
High Response Rate ◽  
Hepatitis C Virus Infection ◽  
Safety And Efficacy ◽  
Chronic Hepatitis C Virus

Abstract We assessed the safety and efficacy of a generic form of ledipasvir-sofosbuvir for the treatment of hepatitis C virus infection in Egyptian adolescents and compared the results with those of treatment with the brand-named form. The generic form resulted in a high response rate, significant improvement in liver function, and mild adverse effects. These results are comparable with those of the brand form at a reduced price.

Sign in / Sign up

Export Citation Format

Share Document